Showing results (61-70 of 143) with videos related to
Sort By:
Pageof 15
Current Atherosclerosis Reports|April 19, 2014
Renal artery stenosis-when to screen, what to stent?Claudine G Jennings, John G Houston, Alison Severn, et al.Pharmacoepidemiology and Drug Safety|July 6, 2010
Automated data capture from free-text radiology reports to enhance accuracy of hospital inpatient stroke codesRobert W V Flynn, Thomas M Macdonald, Nicola Schembri, et al.Trials|April 19, 2015
Does offering an incentive payment improve recruitment to clinical trials and increase the proportion of socially deprived and elderly participants?Claudine G Jennings, Thomas M MacDonald, Li Wei, et al.British Journal of Clinical Pharmacology|November 16, 2011
Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomesIsla S Mackenzie, Thomas M MacDonald, Saad Shakir, et al.Stroke|October 16, 2010
Prescribing antiplatelet medicine and subsequent events after intracerebral hemorrhageRobert W V Flynn, Thomas M MacDonald, Gordon D Murray, et al.Journal of Hypertension|July 16, 2008
Effect on blood pressure of lumiracoxib versus ibuprofen in patients with osteoarthritis and controlled hypertension: a randomized trialThomas M MacDonald, Jean-Yves Reginster, Thomas W Littlejohn, et al.Cerebrovascular Diseases (Basel, Switzerland)|January 21, 2012
Persistence, adherence and outcomes with antiplatelet regimens following cerebral infarction in the Tayside Stroke CohortRobert W V Flynn, Thomas M MacDonald, Gordon D Murray, et al.Journal of Human Hypertension|February 16, 2021
Home blood pressure monitors owned by participants in a large decentralised clinical trial in hypertension: the Treatment In Morning versus Evening (TIME) studyThineskrishna Anbarasan, Amy Rogers, David A Rorie, et al.Therapeutic Advances in Neurological Disorders|December 14, 2018
Evaluation of pregnancy outcomes in patients with multiple sclerosis after fingolimod exposureYvonne Geissbühler, Jere Vile, Gideon Koren, et al.European Journal of Heart Failure|October 1, 2009
A randomized, double-blind, placebo-controlled study to determine the effects of valsartan on exercise time in patients with symptomatic heart failure with preserved ejection fractionHari K Parthasarathy, Burkert Pieske, Marianne Weisskopf, et al.Pageof 15